Literature DB >> 33624600

[Huangqin decoction alleviates ulcerative colitis by regulating ILC3s-TH cell response].

C Zhou1, X Zheng2,3, X Huang2,3, J Su4, M Li2, Z Chen3, M Li2, H Chi5.   

Abstract

OBJECTIVE: To explore the effect of Huangqin decoction (HQD) on group 3 innate lymphoid cells (ILC3s) and helper T cells (Th) for treatment of ulcerative colitis (UC).
OBJECTIVE: Male Balb/c mice were randomly divided into control group, DSS group, mesalazine group (ME, 400 mg/kg), and 2.275 g/kg, 4.55 g/kg and 9.1 g/kg HQD groups. All the mice were given free access to normal chow. Except for those in the normal control group, all the mice were given 3% DSS solution for 7 days to establish models of UC. The mice in ME group and 3 HQD groups were given mesalazine or HQD via oral gavage at the specified doses once a day. Flow cytometry was performed to analyze the ILC3s, MHC Ⅱ, Th1 and Treg in the lamina propria lymphocytes in the colon. Milliplex was performed to determine cytokine levels of in the colon tissues.
OBJECTIVE: Compared with those in DSS group, the mice in the 3 HQD groups all showed obviously lessened symptoms of UC with significantl decreased DAI score (P < 0.001) and macroscopic score (P < 0.001). The results of flow cytometry showed that HQD treatment significantly increased the percentage of ILC3s (P < 0.05) and expression of MHCⅡ (P < 0.05), obviously reduced the proportion of Th1 (P < 0.05) but increased Treg cells (P < 0.05) in the colon tissues. Milliplex showed that HQD treatment significantly reduced the expressions of Th-related pro-inflammatory cytokines including IL-2 (P < 0.05), IL-17A (P < 0.05), IL-23 (P < 0.05), TNF-α (P < 0.05), and IFN-γ (P < 0.05).
OBJECTIVE: HQD alleviates DSS- induced UC in mice by increasing ILC3s and MHC Ⅱ expression to suppress the function of Th17 and Th1 cells and promote Treg and Th2 cells.

Entities:  

Keywords:  Huangqin decoction; helper T cells; innate lymphoid cells; ulcerative colitis

Year:  2021        PMID: 33624600     DOI: 10.12122/j.issn.1673-4254.2021.02.14

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  3 in total

1.  Research on the Protective Effect of MiR-185-3p Mediated by Huangqin-Tang Decoction (HQT) on the Epithelial Barrier Function of Ulcerative Colitis.

Authors:  Zhou Changlin; Zou Ying; Zhang Shuhua; Jiayang Zeng; Honggang Chi
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-21       Impact factor: 2.629

2.  Integrated Network Pharmacology and Gut Microbiota Study on the Mechanism of Huangqin Decoction in Treatment Diabetic Enteritis.

Authors:  Xiaomin Xu; Cheng Fang; Fang Lu; Shumin Liu
Journal:  Appl Bionics Biomech       Date:  2022-04-07       Impact factor: 1.664

Review 3.  Systematic Evaluation of Randomized Clinical Trials of Huangqin Tang in Combination with Mesalazine for Ulcerative Colitis.

Authors:  Chengyu Pan; Mengru Liu; Hui Li; Lanfu Wei; Pengcheng Wang; Kexuan Wu; Xing Ji; Limei Gu; Yaozhou Tian
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-11       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.